ARCT-154, also known as VBC-COV19-154 in Vietnam, is a COVID-19 vaccine candidate developed by Arcturus Therapeutics.
Read more in the app
Who Is Eligible for the COVID Vaccine in 2025, and How to Get It
Covid Vaccine Opponent Tapped to Lead Federal Review Team
COVID vaccine reduces severity of illness, death for adults, especially among at-risk populations - EurekAlert!
Can You Still Get a COVID Vaccine This Fall? Here’s What to Know
Federal Officials May Limit Recommendations for Covid Vaccine
Billions Spent, Billions Saved: The True Cost of the COVID Vaccine
COVID vaccine protected kids from long COVID - EurekAlert!
Feeling Sick After Your COVID Vaccine? According to Scientists, It’s Actually a Good Sign
AstraZeneca's COVID Vaccine Withdrawn – But Let's Untangle The Facts From The Fiction
A New Way to Inspire People to Get a COVID Vaccine
Is the Novavax COVID Vaccine Better than mRNA Vaccines? What We Know So Far
Researchers Who Made COVID Vaccine Possible Awarded Nobel Prize
FDA Panel Recommends a Covid Vaccine Aimed at Only the XBB Variant
New Research Uncovers Potential Explanation for COVID Vaccine Blood Clot Connection
AstraZeneca’s Covid Vaccine May Have Posed a Higher Heart Risk for Young Women, Study Shows
Study examines heart inflammation after COVID vaccine
After Long Delay, Moderna Pays N.I.H. for Covid Vaccine Technique
Kizzmekia Corbett Unlocked the Science of the Covid Vaccine
Covid Vaccine Makers Kept Prepayments for Canceled Shots for Poor Nations
InnovationRx: Health System Quality; Plus, A Yearly Covid Vaccine